Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Otsuka Holdings Company ADR (OTSKY)
Otsuka Holdings Company ADR (OTSKY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 11.05
  • Price/Book 1.23
Trade OTSKY with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.1000 +17.13%
on 02/13/24
20.3700 -1.67%
on 03/01/24
+0.7300 (+3.78%)
since 02/02/24
3-Month
17.1000 +17.13%
on 02/13/24
20.8400 -3.89%
on 01/11/24
+0.8400 (+4.38%)
since 12/04/23
52-Week
14.4201 +38.90%
on 03/16/23
20.8400 -3.89%
on 01/11/24
+5.4600 (+37.47%)
since 03/03/23

Most Recent Stories

More News
AMGN Earnings Spotlight: Analyzing Potential Gains

Drug manufacturer Amgen Inc. (AMGN) is actively pursuing strategic collaborations and making noteworthy strides in the realm of obesity treatments. With the company all set to lift the curtains on its...

AMGN : 277.91 (-0.53%)
CORT : 23.94 (-0.87%)
INCY : 58.26 (-2.44%)
OTSKY : 20.0000 (-0.15%)
Gilead (GILD) Quarterly Earnings: Buy or Sell Signal?

Biotech major Gilead Sciences (GILD) will release its fourth-quarter results on February 6. The company is expected to report growth in earnings over the prior-year quarter, but its revenue is expected...

ASMB : 13.07 (-1.98%)
GILD : 72.18 (-0.10%)
INCY : 58.26 (-2.44%)
OTSKY : 20.0000 (-0.15%)
UTHR : 229.52 (+0.34%)
Is Roivant Sciences (ROIV) the Right Biotech Stock for Your Portfolio?

While Roivant Sciences (ROIV) has been seeing stable revenue growth, its bottom line is in the red. So, will it be worth owning ROIV now? Let’s discuss some of its key financial metrics to gauge its...

INCY : 58.26 (-2.44%)
OTSKY : 20.0000 (-0.15%)
ROIV : 11.55 (+0.61%)
VRTX : 418.11 (-1.40%)
Vertex Pharmaceuticals (VRTX) Post-Earnings Analysis: Is It Time to Buy the Stock?

After a solid third-quarter earnings report, does Vertex Pharmaceuticals (VRTX) deserve a place in your portfolio? Let’s look at its financial metrics to gauge its prospects… Vertex Pharmaceuticals...

CORT : 23.94 (-0.87%)
GILD : 72.18 (-0.10%)
OTSKY : 20.0000 (-0.15%)
VRTX : 418.11 (-1.40%)
Gilead Sciences (GILD) Earnings Forecast and Gameplan

Gilead Sciences (GILD) boasts an impressive product portfolio and has surpassed the consensus estimate on the topline in each of the trailing four quarters. With the company gearing up to post its third...

ALXN : 182.50 (+1.70%)
CORT : 23.94 (-0.87%)
GILD : 72.18 (-0.10%)
OTSKY : 20.0000 (-0.15%)
Regeneron Pharmaceuticals (REGN) Earnings Analysis -- Should Investors Brace for Impact?

Regeneron Pharmaceuticals (REGN) has an impressive revenue and earnings surprise history. So, as the company gears up to post its third-quarter report, is REGN the right pick? Read on... Regeneron...

GILD : 72.18 (-0.10%)
JAZZ : 117.68 (+0.13%)
OTSKY : 20.0000 (-0.15%)
REGN : 955.25 (-1.64%)
Moderna (MRNA) Stock Analysis: Is the Biotech Stock a Buy at This Time?

Biotech company Moderna (MRNA) recently published positive data from its latest flu vaccine trial, garnering investors’ attention. While the company focusing on expanding its product portfolio, is this...

AMGN : 277.91 (-0.53%)
JAZZ : 117.68 (+0.13%)
MRNA : 94.14 (-1.94%)
OTSKY : 20.0000 (-0.15%)
This Big Pharma Company Is Becoming a Psychedelics Stock, but Don't Buy It (Yet)

As the first large pharma operation to make a significant investment in psychedelics, the rewards could be big.

OTSKY : 20.0000 (-0.15%)
Is Now the Time to Buy Into Moderna, Inc. (MRNA)?

Is now the time to invest in Moderna (MRNA) after the company revealed that its updated vaccines would be effective against two new COVID-19 subvariants? Let’s look at its financial metrics to gauge...

ALKS : 29.70 (-0.74%)
GILD : 72.18 (-0.10%)
MRNA : 94.14 (-1.94%)
OTSKY : 20.0000 (-0.15%)
2 Healthcare Stocks Showing Stability With A and B POWR Ratings

The healthcare industry should thrive with accelerated breakthrough developments and a growing market for telemedicine and personalized medicines. Moreover, given the lingering macroeconomic headwinds,...

AMGN : 277.91 (-0.53%)
OTSKY : 20.0000 (-0.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 21.4467
2nd Resistance Point 20.8233
1st Resistance Point 20.4267
Last Price 20.0000
1st Support Level 19.4067
2nd Support Level 18.7833
3rd Support Level 18.3867

See More

52-Week High 20.8400
Last Price 20.0000
Fibonacci 61.8% 18.3876
Fibonacci 50% 17.6301
Fibonacci 38.2% 16.8725
52-Week Low 14.4201

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar